Skip to content

Endoprosthesis Metal Toxicity Study

Evaluation and Clinical Impact of Serum and Blood Metal Ion Levels in Patients With an Endoprosthesis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04755140
Enrollment
20
Registered
2021-02-15
Start date
2021-03-19
Completion date
2024-05-01
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Tumor, Cancer of Bone, Chemotherapy Effect, Cognitive Decline, Cognitive Impairment, Heart Diseases, Memory Problem

Keywords

Endoprosthesis, Metallosis, Toxicity

Brief summary

The purpose of this research is to investigate whether patients who previously had endoprosthesis surgery experience memory, thinking, or heart problems. It will also help determine how often these problems occur.

Detailed description

At your first visit you will be asked to do the following: 1. Sign the consent document. 2. Patient Interview: An interview will be conducted by the study coordinator on the research team. They will ask your past surgical history, health history, medications, and your cognition. 3. Informant Interview: A close friend, spouse of relative of you will be interviewed about your day-day cognition. 4. Memory Interview: You will be evaluated on your memory and thinking skills three total times. One to determine baseline, and then repeated at one year and two years. You will answer questions that evaluate various thinking abilities such as concentration, memory, reasoning, and learning. 5. Blood Draw: You will have a blood draw three times (4.2-5 tablespoons) to determine your baseline, 1 year, and 2 year research results. 6: Echocardiogram: You will be asked to have three echocardiograms. One to determine baseline, and then repeated at one year and two years.

Interventions

BEHAVIORALQuestionnaires

The patient and an informant will be asked to complete a questionnaire about his or hers current and past physical thinking abilities.

BEHAVIORALInterviews

Cognition and memory interviews will take place with the patient.

DIAGNOSTIC_TESTBlood Test

Three blood draws will occur to assess patients immune response, metal levels, and cardiac health.

DIAGNOSTIC_TESTEchocardiogram

Each echocardiogram takes about 3 hours and 30 minutes. This test uses sound waves to look at your heart. The person doing the test will press on your chest with a machine to obtain the pictures. The pressure may be uncomfortable. The echocardiogram will involve an image enhancement agent infusion to obtain better images.

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
National Institute on Aging (NIA)
CollaboratorNIH
Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Patient has an endoprosthesis after extremity malignancy

Exclusion criteria

* Current fracture or infection around the endoprosthesis * Patient is pregnant

Design outcomes

Primary

MeasureTime frameDescription
Titanium Metal LevelsTitanium level will be measured at baseline, 1 year, and 2 yearsThe change in titanium blood ion levels will be measured in ng/mL.
Cobalt Metal LevelsCobalt level will be measured at baseline, 1 year, and 2 yearsThe change in cobalt blood ion levels will be measured in ng/mL.
Chromium Metal LevelsChromium level will be measured at baseline, 1 year, and 2 yearsThe change in chromium blood ion levels will be measured in ng/mL.
Echo - Left Ventricular Ejection FractionEcho's will be taken at baseline, 1 year, and 2 yearsThe echocardiogram will measure changes in LV ejection fraction as a percent.
Echo - Left Ventricular MassEcho's will be taken at baseline, 1 year, and 2 yearsThe echocardiogram will measure changes in LV Mass in grams.
Echo - Heart HypertrophyEcho's will be taken at baseline, 1 year, and 2 yearsThe echocardiogram will measure changes in concentric or eccentric hypertrophy in centimeters.

Secondary

MeasureTime frameDescription
Psychometrist Testing - Memory ScoreTesting will occur at baseline, 1 year, and 2 years.The change in participants' memory will be measured using the Wechsler Adult Memory Scale. The scale is based of scores of 50 to 150. The higher the score the better the outcome. The average outcome will be a score of 100.
Psychometrist Testing - Intelligence ScoreTesting will occur at baseline, 1 year, and 2 years.The change in participants' intelligence will be measured using the Wechsler Adult Intelligence Scale. The scale is based of scores of 50 to 150. The higher the score the better the outcome. The average outcome will be a score of 100.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026